Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 8 studies | 26% ± 10% | |
| adipocyte | 6 studies | 25% ± 8% | |
| ciliated cell | 6 studies | 21% ± 7% | |
| astrocyte | 6 studies | 29% ± 12% | |
| epithelial cell | 5 studies | 29% ± 13% | |
| cardiac muscle cell | 4 studies | 24% ± 2% | |
| GABAergic neuron | 4 studies | 37% ± 14% | |
| glutamatergic neuron | 4 studies | 43% ± 11% | |
| oligodendrocyte precursor cell | 4 studies | 29% ± 11% | |
| macrophage | 4 studies | 19% ± 3% | |
| oligodendrocyte | 4 studies | 25% ± 4% | |
| microglial cell | 3 studies | 20% ± 2% | |
| hepatocyte | 3 studies | 26% ± 12% | |
| endothelial cell of lymphatic vessel | 3 studies | 18% ± 2% | |
| goblet cell | 3 studies | 25% ± 7% | |
| interneuron | 3 studies | 40% ± 21% | |
| kidney loop of Henle epithelial cell | 3 studies | 22% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 1320.21 | 245 / 245 | 100% | 9.05 | 502 / 502 |
| thymus | 100% | 1353.82 | 653 / 653 | 100% | 9.24 | 603 / 605 |
| breast | 100% | 1240.96 | 459 / 459 | 99% | 10.93 | 1110 / 1118 |
| pancreas | 100% | 753.96 | 328 / 328 | 99% | 7.32 | 176 / 178 |
| brain | 99% | 610.04 | 2615 / 2642 | 100% | 7.37 | 704 / 705 |
| kidney | 100% | 2048.08 | 89 / 89 | 99% | 8.50 | 888 / 901 |
| ovary | 100% | 1579.59 | 180 / 180 | 98% | 7.47 | 420 / 430 |
| bladder | 100% | 1277.00 | 21 / 21 | 97% | 8.88 | 491 / 504 |
| esophagus | 100% | 880.28 | 1445 / 1445 | 97% | 6.37 | 178 / 183 |
| stomach | 100% | 680.15 | 359 / 359 | 97% | 5.70 | 278 / 286 |
| lung | 100% | 1062.85 | 578 / 578 | 97% | 5.93 | 1122 / 1155 |
| intestine | 100% | 1069.56 | 966 / 966 | 96% | 5.81 | 506 / 527 |
| adrenal gland | 100% | 861.62 | 258 / 258 | 94% | 4.81 | 216 / 230 |
| uterus | 100% | 1252.77 | 170 / 170 | 93% | 6.02 | 428 / 459 |
| liver | 100% | 948.40 | 226 / 226 | 92% | 4.65 | 372 / 406 |
| skin | 100% | 1033.40 | 1809 / 1809 | 80% | 3.84 | 377 / 472 |
| blood vessel | 100% | 904.39 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 5.14 | 29 / 29 |
| spleen | 100% | 1440.91 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.44 | 1 / 1 |
| adipose | 100% | 1086.80 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| heart | 100% | 614.55 | 857 / 861 | 0% | 0 | 0 / 0 |
| muscle | 97% | 414.68 | 781 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 94% | 627.21 | 875 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 91% | 4.94 | 41 / 45 |
| eye | 0% | 0 | 0 / 0 | 54% | 2.31 | 43 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZNF44 |
| Protein name | Zinc finger protein 44 (Gonadotropin-inducible ovary transcription repressor 2) (GIOT-2) (Zinc finger protein 55) (Zinc finger protein 58) (Zinc finger protein KOX7) Zinc finger protein 44 |
| Synonyms | KOX7 GIOT2 ZNF55 hCG_2002471 ZNF58 |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | ENST00000397742.7 [P15621-2] A0A8V8TMG8 ENST00000393337.7 [P15621-3] ENST00000697576.1 E2QRP2 ENST00000355684.6 P15621 F8W7T7 M0R160 ENST00000354656.3 ENST00000356109.10 [P15621-1] ENST00000600003.5 |